Cannara Biotech, Inc. (TSE:LOVE) has released an update.
Cannara Biotech Inc. has reported a significant increase in financial results for Q2 2024, with net revenue rising 51% to $19.7 million and gross profit up by 77.2% to $7.1 million compared to the same quarter last year. The company has also achieved its twelfth consecutive quarter of positive Adjusted EBITDA, reaching $3.5 million. These results underscore Cannara’s ongoing growth and market expansion, as it advances towards becoming a leading cannabis producer in Canada.
For further insights into TSE:LOVE stock, check out TipRanks’ Stock Analysis page.
